These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29924669)

  • 1. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
    Wiegand S; Wichmann G; Dietz A
    Lymphat Res Biol; 2018 Aug; 16(4):330-339. PubMed ID: 29924669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sirolimus in children with lymphatic malformations of the head and neck.
    Wiegand S; Dietz A; Wichmann G
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3801-3810. PubMed ID: 35526176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
    Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
    Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
    Leducq S; Caille A; Barbarot S; Bénéton N; Bessis D; Boccara O; Bursztejn AC; Chiaverini C; Dompmartin A; Droitcourt C; Gissot V; Goga D; Guibaud L; Herbreteau D; Le Touze A; Léauté-Labrèze C; Lorette G; Mallet S; Martin L; Mazereeuw-Hautier J; Phan A; Plantin P; Quéré I; Vabres P; Bourgoin H; Giraudeau B; Maruani A;
    Trials; 2019 Dec; 20(1):739. PubMed ID: 31847908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
    Shoji MK; Shishido S; Freitag SK
    Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
    Durand R; Reid JR; Belasco JB; Shellikeri S; Calle-Toro JS; Cahill AM; Srinivasan A
    AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
    [No Abstract]   [Full Text] [Related]  

  • 8. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
    Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations.
    Alemi AS; Rosbe KW; Chan DK; Meyer AK
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2466-9. PubMed ID: 26549380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.
    Marchand A; Caille A; Gissot V; Giraudeau B; Lengelle C; Bourgoin H; Largeau B; Leducq S; Maruani A
    Trials; 2022 Jul; 23(1):557. PubMed ID: 35804404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
    JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex lymphatic malformations in pediatrics: a review of treatment options.
    Pessanha I; Bravo M; Piedade C; Lopes MF
    Minerva Pediatr (Torino); 2022 Feb; 74(1):70-80. PubMed ID: 35283478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review.
    Saibene AM; Rosso C; Felisati G; Pignataro L; Schindler A; Ghilardi G; Colletti G; Gaffuri M; Mozzanica F
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3529-3540. PubMed ID: 37115326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation.
    Strychowsky JE; Rahbar R; O'Hare MJ; Irace AL; Padua H; Trenor CC
    Laryngoscope; 2018 Jan; 128(1):269-276. PubMed ID: 28782106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical rapamycin and microcystic lymphatic malformations.
    Gu Y; Sebaratnam DF
    J Am Acad Dermatol; 2024 Jan; 90(1):e29-e30. PubMed ID: 37717734
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
    Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
    Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.
    Kim D; Benjamin L; Wysong A; Hovsepian D; Teng J
    Dermatol Ther; 2015; 28(4):218-21. PubMed ID: 25753853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus in the Treatment of Microcystic Lymphatic Malformations: A Systematic Review.
    Teng JMC; Hammill A; Martini J; Treat J
    Lymphat Res Biol; 2023 Apr; 21(2):101-110. PubMed ID: 35852876
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
    Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric case of acquired progressive lymphatic anomaly treated with sirolimus.
    Komamizu S; Ozeki M; Hayashi D; Endo S; Hori-Hirose Y; Sasaki S; Ohnishi H
    Pediatr Int; 2023 Jan; 65(1):e15497. PubMed ID: 36749179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.